H Yokozaki Selected Research

Skin Neoplasms (Skin Cancer)

6/2000

[Carcinogenesis through abnormalities of DNA repair genes].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

H Yokozaki Research Topics

Disease

12	Neoplasms (Cancer) 01/2011 - 01/2000
12	Carcinoma (Carcinomatosis) 03/2007 - 01/2000
7	Stomach Neoplasms (Stomach Cancer) 08/2001 - 01/2000
4	Carcinogenesis 08/2001 - 01/2000
3	Colorectal Neoplasms (Colorectal Cancer) 01/2011 - 01/2001
3	Adenocarcinoma 01/2001 - 01/2000
2	Squamous Cell Carcinoma of Head and Neck 01/2001 - 04/2000
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2009
1	Esophageal Squamous Cell Carcinoma 07/2008
1	Neoplasm Metastasis (Metastasis) 03/2007
1	Mouth Neoplasms (Oral Cancer) 01/2001
1	Colonic Neoplasms (Colon Cancer) 01/2001
1	Adenosquamous Carcinoma 10/2000
1	Signet Ring Cell Carcinoma 10/2000
1	Microsatellite Instability 10/2000
1	Skin Neoplasms (Skin Cancer) 06/2000
1	Xeroderma Pigmentosum (Kaposi's Disease) 06/2000
1	Hypersensitivity (Allergy) 06/2000
1	Head and Neck Neoplasms (Head and Neck Cancer) 04/2000
1	Hyperplasia 03/2000
1	Metaplasia 03/2000
1	Infections 03/2000
1	Chromosomal Instability (Chromosome Stability) 01/2000

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2011 - 03/2000
6	DNA (Deoxyribonucleic Acid)IBA 09/2001 - 02/2000
6	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2001 - 01/2000
5	Messenger RNA (mRNA)IBA 03/2007 - 01/2001
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2001 - 01/2001
3	Alitretinoin FDA Link 01/2001 - 04/2000
3	Cell Adhesion MoleculesIBA 01/2001 - 01/2000
3	Cyclin EIBA 01/2001 - 01/2000
2	ChromatinIBA 01/2011 - 08/2001
2	TankyrasesIBA 09/2001 - 01/2001
2	telomerase RNA (bTR)IBA 09/2001 - 01/2001
2	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 09/2001 - 01/2001
2	Nuclear Proteins (Protein, Nuclear)IBA 09/2001 - 01/2001
2	AnkyrinsIBA 09/2001 - 01/2001
2	O(6)-Methylguanine-DNA MethyltransferaseIBA 09/2001 - 01/2001
2	retinoic acid receptor betaIBA 08/2001 - 01/2001
2	Cadherins (E-Cadherin)IBA 01/2001 - 10/2000
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2001 - 01/2000
2	Trefoil FactorsIBA 02/2000 - 01/2000
1	Biological ProductsIBA 01/2011
1	Small Interfering RNA (siRNA)IBA 01/2011
1	WW Domain-Containing OxidoreductaseIBA 05/2009
1	Transcription Factors (Transcription Factor)IBA 07/2008
1	Tyrosine (L-Tyrosine)FDA Link 03/2007
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2007
1	MethyltransferasesIBA 09/2001
1	Decitabine FDA Link 09/2001
1	EnzymesIBA 09/2001
1	Cyclin-Dependent Kinase Inhibitor p16IBA 09/2001
1	Complementary DNA (cDNA)IBA 07/2001
1	Phosphotransferases (Kinase)IBA 07/2001
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2001
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 01/2001
1	CateninsIBA 01/2001
1	Histones (Histone)IBA 01/2001
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2001
1	Interleukin-15 (Interleukin 15)IBA 01/2001
1	theasinensin AIBA 12/2000
1	Histone Deacetylase InhibitorsIBA 12/2000
1	trichostatin A (A 300)IBA 12/2000
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2000
1	beta CateninIBA 10/2000
1	Pyrimidine DimersIBA 06/2000
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 04/2000
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2000
1	Reactive Nitrogen SpeciesIBA 03/2000
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2000
1	Mucin-1 (CA 15-3 Antigen)IBA 02/2000
1	Keratins (Keratin)IBA 02/2000
1	VimentinIBA 02/2000
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2000
1	CyclinsIBA 01/2000
1	Growth Factor ReceptorsIBA 01/2000

Therapy/Procedure

1	Molecular Targeted Therapy 01/2001